Key terms

About CTMX

CytomX Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company, which engages in the development of conditionally activated, biologics localized to the tumor microenvironment. The company was founded by Frederick W. Gluck and Nancy E. Stagliano in September 2010 and is headquartered in South San Francisco, CA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest CTMX news

Apr 08 8:06am ET CytomX Therapeutics doses first patient in CX-2051 Phase 1 study Apr 03 8:19am ET CytomX announces $5M milestone triggered in Astellas Pharma TCB collaboration Mar 25 6:17am ET CytomX Therapeutics: A Balanced Hold Rating Amidst Financial Uncertainty and Clinical Progress Mar 22 4:23pm ET CytomX Therapeutics Welcomes New Director and Updates Bylaws Mar 21 8:10am ET CytomX Therapeutics appoints Zhen Su to board of directors Mar 18 8:08am ET CytomX Therapeutics announces milestone achievement in PROBODY TCB Mar 13 2:02am ET CytomX Therapeutics Braces for Increased Compliance Costs as it Outgrows ‘Smaller Company’ Status Mar 12 8:20am ET Analysts Conflicted on These Healthcare Names: Insmed (INSM), Oric Pharmaceuticals (ORIC) and CytomX Therapeutics (CTMX) Mar 12 7:29am ET CytomX Therapeutics price target lowered to $3.25 from $3.30 at BMO Capital Mar 12 7:10am ET Analysts Have Conflicting Sentiments on These Healthcare Companies: Legend Biotech (LEGN) and CytomX Therapeutics (CTMX) Mar 12 6:05am ET J.P. Morgan Keeps Their Sell Rating on CytomX Therapeutics (CTMX) Mar 12 4:41am ET Analysts Have Conflicting Sentiments on These Healthcare Companies: Legend Biotech (LEGN), ACADIA Pharmaceuticals (ACAD) and CytomX Therapeutics (CTMX) Mar 11 8:05am ET Options Volatility and Implied Earnings Moves Today, March 11, 2024 Mar 01 11:04am ET Biotech Alert: Searches spiking for these stocks today Feb 29 10:57am ET Biotech Alert: Searches spiking for these stocks today Feb 29 10:57am ET Biotech Alert: Searches spiking for these stocks today Jan 24 8:04am ET CytomX Therapeutics announces FDA clearance of IND applications for CX-2051

No recent news articles are available for CTMX

No recent press releases are available for CTMX

CTMX Financials

1-year income & revenue

Key terms

CTMX Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

CTMX Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms